SmithKine Beecham, the UK drugs company is ditching a potentiall important product for the cippling bone condition osteoporosis. The company was abadoning development of idoxifene as a treatment of
Technology Partners: MimirTech
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/smithkline-beecham-ends-development-bone-drug
[2] http://admin.indiaenvironmentportal.org.in/category/newspaper/financial-times-london
[3] http://admin.indiaenvironmentportal.org.in/category/thesaurus/health
